These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 26253079)

  • 41. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.
    Preston A
    Hum Vaccin Immunother; 2016 May; 12(5):1274-6. PubMed ID: 26889694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. JMM Profile:
    Fry NK; Campbell H; Amirthalingam G
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A nested case-control study measuring pertussis vaccine effectiveness and duration of protection in Manitoba, Canada, 1992-2015: A Canadian Immunization Research Network Study.
    Wilkinson K; Righolt CH; Kwong JC; Schwartz KL; Russell ML; Crowcroft NS; Mahmud SM
    Vaccine; 2019 Nov; 37(48):7132-7137. PubMed ID: 31564453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bordetella pertussis and pertussis vaccines.
    Guiso N
    Clin Infect Dis; 2009 Nov; 49(10):1565-9. PubMed ID: 19839747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-Term Analysis of Pertussis Vaccine Immunity to Identify Potential Markers of Vaccine-Induced Memory Associated With Whole Cell But Not Acellular Pertussis Immunization in Mice.
    Weaver KL; Blackwood CB; Horspool AM; Pyles GM; Sen-Kilic E; Grayson EM; Huckaby AB; Witt WT; DeJong MA; Wolf MA; Damron FH; Barbier M
    Front Immunol; 2022; 13():838504. PubMed ID: 35211125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Why do pertussis vaccines fail?
    Cherry JD
    Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
    [No Abstract]   [Full Text] [Related]  

  • 49. Factors contributing to pertussis resurgence.
    He Q; Mertsola J
    Future Microbiol; 2008 Jun; 3(3):329-39. PubMed ID: 18505398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acellular pertussis vaccines in adults.
    Keitel WA; Edwards KM
    Infect Dis Clin North Am; 1999 Mar; 13(1):83-94, vi. PubMed ID: 10198793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. As immunity wanes, whooping cough returns.
    Chin TL
    Health Aff (Millwood); 2014 Dec; 33(12):2095-8. PubMed ID: 25489026
    [No Abstract]   [Full Text] [Related]  

  • 52. Pathogenesis and histopathology of pertussis: implications for immunization.
    Cherry JD; Paddock CD
    Expert Rev Vaccines; 2014 Sep; 13(9):1115-23. PubMed ID: 24992986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Licensed pertussis vaccines in the United States. History and current state.
    Klein NP
    Hum Vaccin Immunother; 2014; 10(9):2684-90. PubMed ID: 25483496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resurgence of pertussis calls for re-evaluation of pertussis animal models.
    van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA
    Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy of acellular pertussis vaccines].
    Wirsing von König CH; Finger H
    Immun Infekt; 1995 Aug; 23(4):125-9. PubMed ID: 7558115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there a need for a new generation of vaccines against pertussis?
    Storsaeter J; Wolter J
    Expert Opin Emerg Drugs; 2006 May; 11(2):195-205. PubMed ID: 16634696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
    Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
    Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.